# Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants

> **NCT00833482** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 185 (actual)

## Conditions studied

- Human Immunodeficiency Virus Type 1 (HIV-1)
- HIV Infections

## Interventions

- **DRUG:** Voriconazole
- **DRUG:** Atazanavir
- **DRUG:** Ritonavir

## Key facts

- **NCT ID:** NCT00833482
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-07
- **Final completion:** 2011-02
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2012-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00833482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00833482, "Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00833482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*